Protocol
The Walsh Protocol and Walsh Biotypes: A Biochemical Approach to Mental Health
Two people can be given the same diagnosis, the same antidepressant and the same supplements, and have completely different results. One improves. The other feels flat, wired or worse.
If that sounds familiar, your biochemistry may be part of the reason.
Most people who find their way to the Walsh Protocol have already tried a few things. Perhaps something helped for a while but didn’t last. Perhaps you’ve tried different medications or supplements and wondered why something that seemed to work so well for someone else didn’t work the same way for you. At some point, you may start to wonder whether your own biochemistry is part of the story.
That’s the question at the heart of the Walsh Protocol. Developed by research scientist Dr William Walsh, it’s a nutrient-based approach to mental health that looks for measurable biochemical patterns, known as Walsh biotypes or Walsh biochemical types, that may influence how the brain makes and uses serotonin, dopamine and its other chemical messengers. The idea behind it is called biochemical individuality.
I was trained directly by Dr Walsh through the Walsh Research Institute, and I use his model to help people understand why some treatments may have suited them and others haven’t, and what a more individual plan could look like. A biotype is never the whole person. But for the right person, it can explain a great deal.
What Is the Walsh Protocol?
The core principle is simple:
➡️ Treat the biotype, not just the diagnosis.
The Walsh Protocol is a system of individualised nutrient therapy. It uses targeted testing to identify measurable biochemical imbalances that can contribute to mental health symptoms, then uses specific nutrients to help correct them.
Rather than starting from the psychiatric label alone, it looks for patterns such as methylation imbalance, copper overload, pyrrole disorder and oxidative stress. The diagnosis still matters. The biochemistry adds another layer of information, and it’s a layer that often goes unchecked.
Within the Walsh model, many cases of depression, anxiety, ADHD and psychosis involve imbalances like these, and many of them can be identified and corrected.
The protocol was developed by Dr William J. Walsh, an American research scientist who has spent more than four decades studying the biochemistry of people with mental health conditions. His work builds on that of Dr Carl Pfeiffer, one of the pioneers of nutritional psychiatry, and draws on a clinical database of more than 30,000 patients and around 3 million laboratory assays.
Nutrient therapy is usually well tolerated, though it isn’t free of side effects. It works alongside good medical care rather than replacing it, and I don’t ask people to stop their psychiatric medication.
Hear Dr. William Walsh explain the science behind nutrient therapy (60-second overview)
In this short video, Dr William Walsh explains the thinking behind his biochemical approach to mental health and how targeted nutrient therapy is used within the Walsh model.
Dr. Walsh’s Book: Nutrient Power
If you’d like to understand the Walsh approach in more depth, I highly recommend Dr Walsh’s book Nutrient Power: Heal Your Biochemistry and Heal Your Brain.
Written for a general audience, it explains his work on methylation, copper and zinc balance, pyrrole disorder and biochemical individuality, and how these patterns may relate to depression, ADHD, autism, schizophrenia and other mental health conditions.
It’s a detailed and, in places, quite technical book — but it’s the book I most often recommend to clients who want to understand the thinking behind the Walsh approach.
Meet Dr. William J. Walsh — Pioneer of Nutrient Psychiatry
Dr William J. Walsh is an internationally recognised scientist, educator and pioneer in the field of nutrient-based psychiatry. Over more than four decades, Dr Walsh has developed nutrient-based biochemical treatments for a wide range of mental health conditions, with a focus on individualised nutrient therapy.
His contributions include:
• Discovery of five core biochemical subtypes of depression (the Walsh Biotypes)
• Identification of copper/zinc imbalances in mental illness
• The Walsh Theory of Schizophrenia
Dr Walsh began his work in the 1970s at Argonne National Laboratory, organising a prison volunteer program to study violent offenders. That early research compared the blood chemistry of people with a history of violent behaviour with that of people without one, and many of his later findings on zinc, copper and methylation grew out of it. His forensic work went on to include biochemical analysis for medical examiners, coroners, Scotland Yard and the FBI.
Through his collaboration with Dr Carl Pfeiffer, a pioneer in orthomolecular psychiatry, Dr Walsh analysed biochemical profiles of over 30,000 individuals, building a database of more than 3 million laboratory assays. Dr Pfeiffer’s earlier work on histamine, zinc, vitamin B6 and pyrroles laid much of the groundwork that Dr Walsh went on to develop and extend.
He later served as chief scientist at the Pfeiffer Treatment Center in Illinois, named after Dr Pfeiffer, before founding the Walsh Research Institute in 2008. The Institute has since trained more than 1,200 practitioners from over 80 countries, including Australia, where Dr Walsh has run physician training programs. He holds a PhD in chemical engineering, has authored more than 200 scientific articles and reports, and holds five patents.
The Five Core Walsh Biotypes
Each biotype has a unique pattern of nutrient imbalance and distinct clinical presentation. Understanding your biotype allows for more personalized, effective treatment.
Undermethylation
Undermethylation is one of the most commonly observed patterns among people with depression, OCD, anorexia and autism. In the Walsh model, people with this pattern tend to have raised whole-blood histamine, reduced serotonin activity and poor tolerance of folate-based supplements. They are often strong-willed, perfectionistic, competitive and experience high inner tension.
Clinically, these individuals may appear high-functioning, driven and achievement-focused, while underneath they can struggle with inner tension, obsessive or ruminative thinking, anxiety and mood instability. They may keep pushing themselves hard even when they’re struggling. Seasonal allergies and addictive behaviours are also common.
Folate is where this biotype becomes counterintuitive. In the Walsh model, folate increases the activity of serotonin and dopamine transporters, so less of these messengers is left available between nerve cells. That’s why people with this pattern may feel worse on folic acid, folinic acid or methylfolate, even though folate is usually thought of as good for mood. Mainstream research has found methylfolate helpful for some people as an add-on to antidepressants, which is exactly why folate decisions need to be made individually rather than by rule.
In Australia, most bread is made from flour with folic acid added by law, so someone with this pattern may be getting more folic acid than they realise.
Biochemical support may include nutrients such as SAMe, methionine, calcium, magnesium, zinc and sometimes vitamin B6. SAMe can trigger hypomania or mania in people with bipolar disorder, so it requires particular care in anyone with bipolar disorder or a history suggestive of it.
Within the Walsh model, and in my own clinical experience, people with this pattern may respond well to SSRI antidepressants. Some people, however, still experience emotional blunting or loss of motivation. That’s something to discuss with the prescribing clinician rather than changing medication independently.
🧪 Key Tests: Whole Blood Histamine, SAM/SAH Ratio
🧬 BalanSoul testing packages: Pfeiffer Protocol, Methylation Panel
Overmethylation (Folate Deficiency)
Overmethylation presents as the opposite side of the methylation spectrum. In the Walsh model, people with this pattern tend to show higher serotonin, dopamine and norepinephrine activity, which may be associated with anxiety, sleep disturbance, food and chemical sensitivities and difficulty with focus. They are often described as empathetic, sociable, deeply sensitive or creative, and may experience high anxiety or panic tendencies, rapid thoughts, sleep disturbance, food or chemical sensitivities, difficulty with focus, low libido or underachievement despite their potential.
Rather than thriving on methyl donors, they often react poorly to methionine, SAMe and SSRIs. The Walsh approach commonly uses nutrients including folate, vitamin B3 (niacinamide/nicotinamide), vitamin B12 — usually hydroxocobalamin — zinc and vitamin C.
It can seem odd to give folate and B12, which support methylation, to someone described as overmethylated. Dr Walsh’s explanation is that folate’s effect on neurotransmitter transporter gene expression can outweigh its role as a methylation nutrient, producing a different overall effect.
In Dr Walsh’s clinical database, overmethylation was found in approximately 64% of people with panic disorder, 28% with ADHD, 20% with depression and 10% with schizophrenia. These are Walsh-model clinical figures rather than population prevalence estimates.
🧪 Key Tests: Whole Blood Histamine, SAM/SAH Ratio, Serum Copper and Zinc
🧬 BalanSoul testing package: Overmethylation Lab Panel
Pyrrole Disorder (Mauve Factor)
Pyrrole disorder, also known as pyroluria or mauve factor, describes raised levels of a compound called hydroxyhemopyrrolin-2-one (HPL) in the urine. HPL was originally misidentified as kryptopyrrole, which is why you may still see that older name used.
Within the Walsh model, raised HPL is associated with increased requirements for vitamin B6 and zinc — two nutrients important for mood, stress tolerance and neurotransmitter function. Dr Walsh regarded pyrrole disorder as an inherited biochemical tendency associated with haem production, although the exact mechanism remains an area of investigation.
The pattern is commonly associated with poor stress tolerance and feeling easily overwhelmed, particularly during periods of increased stress. Other features may include severe anxiety, irritability or mood swings, emotional volatility, explosive anger, poor dream recall, memory difficulties and sensitivity to light, sound or noise. Some people also report frequent infections or difficulty coping when stress increases.
Walsh-style treatment commonly includes zinc, vitamin B6 — often as P5P — evening primrose oil and antioxidant support, with treatment adjusted according to the person’s results and response.
Vitamin B6 deserves sensible monitoring. Walsh protocols have traditionally used relatively generous therapeutic amounts, while Australian TGA guidance takes a more conservative approach because supplemental B6 has been associated with peripheral neuropathy. B6 is therefore dosed individually and monitored, and tingling, burning or numbness should be reported promptly.
Pyrrole disorder isn’t a recognised medical diagnosis and has been studied less than the other Walsh patterns. In Walsh-trained practice, however, raised urinary HPL alongside the clinical picture and other biochemical findings can be useful information. I never interpret a pyrrole result on its own.
🧪 Key Test: Urinary Pyrroles (HPL)
🧬 BalanSoul testing package: Pyrroluria Panel
Copper Overload
In the Walsh model, copper overload describes a tendency towards excessive copper, particularly the unbound or “free” copper that isn’t carried by its main binding protein, ceruloplasmin.
This pattern is commonly described in women, children with ADHD or behavioural difficulties, and people with anxiety, postpartum depression or schizophrenia. One of its more distinctive features can be a hormonal pattern, with symptoms appearing or worsening around puberty, pregnancy, the postpartum period, oral contraceptive use or menopause. Oestrogen can raise circulating copper, partly by increasing ceruloplasmin, which helps explain why copper commonly rises during pregnancy and with the oral contraceptive pill. Low zinc status and environmental copper exposure may add to the picture.
Copper is involved in converting dopamine to norepinephrine (noradrenaline), so within the Walsh model excessive copper activity is associated with high anxiety, emotional reactivity, racing thoughts, poor concentration, insomnia, agitation, irritability and sometimes episodes of rage.
This is why I don’t look at serum copper alone. I assess serum copper, plasma zinc and ceruloplasmin and calculate unbound/free copper to get a more useful picture.
Treatment may include zinc, molybdenum, manganese, taurine and antioxidant support, together with reducing excessive copper exposure. For someone with confirmed copper overload, I may also recommend reducing particularly copper-rich foods such as liver, shellfish, chocolate, nuts and seeds. That’s an individual recommendation for someone with this pattern, not a general low-copper diet for everyone.
Zinc is introduced gradually and monitored. Within the Walsh model, increasing zinc too quickly can sometimes temporarily aggravate irritability, anxiety or sleep — often referred to as “copper dumping.” Longer-term zinc supplementation also needs monitoring because excessive zinc can eventually push copper too low.
🧪 Key Tests: Serum Copper, Plasma Zinc, Ceruloplasmin, Calculated Free (Unbound) Copper
🧬 BalanSoul testing package: Pfeiffer Protocol
Toxic Metal Overload
Toxic metal overload is an often-overlooked pattern within the Walsh approach. It refers to situations in which mental health or neurological symptoms may be worsened by significant exposure to metals such as lead, cadmium, mercury or arsenic. In depression, one of the patterns described within the Walsh model is a persistent, unrelenting form of depression accompanied by cognitive symptoms or irritability, sometimes without an obvious emotional trigger.
At sufficient exposure levels, toxic metals can interfere with enzymes, increase oxidative stress and affect nervous-system function. Exposure history matters: possible sources include older lead-based paint, industrial or mining environments, contaminated dust or water, and certain occupational exposures.
This pattern may be considered when depression has no obvious emotional trigger or hasn’t responded as expected. Other possible features include brain fog, poor concentration or memory, irritability or anger, fatigue, headaches, mood changes and learning difficulties, particularly when there is a plausible history of toxic-metal exposure.
Assessment may include whole-blood elements, unprovoked urinary heavy metals and hair tissue mineral analysis as a screening tool, interpreted alongside the exposure history and other clinical findings.
Treatment begins with the most important step: identify and reduce ongoing exposure. Nutritional support may include nutrients involved in antioxidant and normal detoxification pathways, such as zinc, selenium, glutathione, vitamin C, taurine and alpha-lipoic acid (ALA).
If testing suggests a significant toxic-metal burden, medical assessment is appropriate. Chelation is a medical treatment with genuine risks and should only be used when a doctor has confirmed that it is indicated.
Toxic-metal patterns can overlap with other Walsh biotypes, particularly pyrrole disorder and copper imbalance, so treatment needs to be individualised.
🧪 Key Tests: Whole Blood Elements Panel, Urinary Heavy Metals (unprovoked), Hair Tissue Mineral Analysis (screening)
🧬 BalanSoul testing package: Heavy Metal/Toxin Clearance Panel
Discover Your Walsh Biotype — Free Questionnaire
You’ll receive a personalized bar graph of your likely biotype scores.
🔒 No cost, no spam — just insights.
Methylation in Mental Illness
Methylation is one of the body’s most fundamental chemical processes. It helps regulate gene activity and is involved in the production and metabolism of neurotransmitters such as serotonin, dopamine and norepinephrine.
Within the Walsh Protocol, methylation is particularly important because people can show very different biochemical patterns — and those differences may influence how they respond to nutrients, supplements and medications.
Dr Walsh’s clinical data suggest that approximately:
• 70% of people have normal methylation
• 22% are undermethylated
• 8% are overmethylated
That means most people fall within the normal range. But for the remaining group, identifying an undermethylated or overmethylated pattern can help explain why something that benefits one person may be ineffective — or even make another person feel worse.
Folate is a good example. Within the Walsh model, people who are undermethylated may sometimes feel worse with folic acid, folinic acid or methylfolate, while folate is commonly used as part of the nutritional approach for overmethylation.
That’s why I don’t recommend treating “methylation” from symptoms or an MTHFR result alone. The pattern needs to be assessed in context.
Disorders associated with undermethylation:
- Autism Spectrum Disorder (98%)
- Antisocial Personality Disorder (95%)
- Schizoaffective Disorder (90%)
- Oppositional Defiant Disorder (85%)
- Anorexia (82%)
- Depression (38%)
Disorders Associated with Overmethylation:
- Panic Disorder (64%)
- ADHD (28%)
- Depression (18%)
- Schizophrenia (10%)
Figures above are from Dr Walsh’s clinical database and describe the proportion of people with these diagnoses who were classified as undermethylated within the Walsh model. They are not general-population prevalence estimates.
MTHFR Is Not the Same as Undermethylation
This is one of the most common points of confusion I see.
An MTHFR gene variant affects an enzyme involved in folate metabolism. It does not, by itself, tell you whether you’re undermethylated or overmethylated in the Walsh sense.
That’s an important distinction because someone can have an MTHFR variant and still have a normal methylation pattern — or even show features of overmethylation. Treating an MTHFR result automatically with high-dose methylfolate can therefore be the wrong approach for some people.
I look at genetics as one piece of the biochemical picture, alongside symptoms, medication history and relevant laboratory markers rather than treating a single gene result as the diagnosis.
How the Walsh Biotypes Appear in Clinical Depression
Depression doesn’t have one biochemical pattern.
In Dr William Walsh’s clinical database, people diagnosed with depression showed several distinctly different biochemical profiles. The largest group was undermethylated, while others showed overmethylation (folate deficiency), copper overload, pyrrole disorder or toxic-metal patterns.
That’s important because people with the same diagnosis may respond very differently to the same treatment. A nutrient that suits one biochemical pattern may be unhelpful — or sometimes poorly tolerated — in another.
The chart shows the distribution Dr Walsh reported among people with clinical depression:
- Undermethylation — 38%
- Overmethylation (Folate Deficiency) — 20%
- Copper Overload — 17%
- Pyrrole Disorder — 15%
- Toxic Metal Overload — 5%
- Other — 5%
Different biotypes can respond very differently to treatment — which is why a one-size-fits-all approach can easily miss the mark.
Biotyping helps us look beyond the diagnosis and match nutrient strategies more closely to your individual biochemistry — including identifying approaches that may help one biochemical pattern but be poorly suited to another.
Why Biotyping Matters — Avoiding Treatment Misfires
Not all depression is created equal.
What helps one person may be poorly suited to another — because the biochemical patterns underlying their symptoms can be different.
🕊️ Undermethylators may respond well to methyl donors such as SAMe, while folate can sometimes make symptoms worse.
🧬 Overmethylators may respond poorly to SSRIs or methyl donors, while folate and niacinamide are commonly used within the Walsh approach.
⚖️ Copper overload calls for careful assessment of copper, zinc and ceruloplasmin rather than assuming the psychiatric diagnosis tells us what nutritional support is needed.
🛡️ Pyrrole disorder may call for targeted zinc and vitamin B6/P5P support, guided by testing and the broader clinical picture.
👉 This is why we don’t guess. We test.
At BalanSoul, biotype testing can be an important part of understanding your individual biochemistry. Where it’s clinically relevant, I use your symptoms, history and laboratory results together to build a more individualised treatment plan — rather than simply guessing which nutrients might suit you.
Summary of Key Biotypes
| Biotype | Core Biochemical Features | Typical Clinical Clues |
|---|---|---|
Undermethylation | Low SAM/SAH ratio; often raised whole-blood histamine | Perfectionism, high drive, obsessive/ruminative thinking, inner tension |
Overmethylation | SAM/SAH ratio may be high-normal; often low whole-blood histamine | Anxiety or panic, rapid thoughts, sleep disturbance, food/chemical sensitivities |
Pyrrole Disorder | Elevated urinary HPL; often low zinc and B6 | Poor stress tolerance, easily overwhelmed, poor dream recall, irritability/mood swings |
Copper Overload | High copper relative to zinc; elevated unbound/free copper may be present | Anxiety, racing thoughts, irritability; symptoms may track hormonal transitions |
Toxic Metal Overload | Significant toxic-metal exposure/burden; oxidative stress may be involved | Persistent, unrelenting depression, brain fog, poor concentration or memory, irritability |
Discover Your Walsh Biotype — Free Questionnaire
📝 Take our free Walsh Protocol Questionnaire — a 70+ question self-assessment based on Dr William J. Walsh’s work — and see which Walsh biotype patterns most closely match your symptoms and traits.
You’ll receive a personalised bar graph showing your likely biotype scores, giving you a useful starting point for understanding which patterns may be worth investigating further.
🔒 No cost, no spam — just insights.
The questionnaire is a screening tool, not a diagnosis. Walsh biotypes are confirmed through clinical assessment and relevant laboratory testing.
Other Less Common Biochemical Imbalances
The five major Walsh biotypes are only part of the biochemical picture. Other nutritional and metabolic patterns can also affect mood, cognition and mental health, and they may overlap with one or more of the main biotypes.
This is one reason I don’t use Walsh biotyping in isolation. Where relevant, I also consider factors such as blood-sugar regulation, digestion and nutrient absorption, fatty-acid status and other contributors that may be affecting the individual.
Glucose Dyscontrol
Unstable blood-sugar regulation can contribute to irritability, fatigue, brain fog, anxiety and mood changes, particularly when symptoms occur between meals. Skipping meals or relying heavily on high-glycaemic foods may make these fluctuations worse.
Support is individualised and may include changes to meal composition, protein and fibre intake, together with relevant nutrients where indicated.
Malabsorption
Even with a nutritious diet, poor digestion or nutrient absorption can contribute to deficiencies that affect brain and nervous-system function. This may be relevant in people with digestive symptoms, food sensitivities or chronic gastrointestinal inflammation.
Where indicated, I investigate the underlying cause rather than simply adding more supplements. Support may include dietary changes, digestive support and strategies directed at the gut and nutrient absorption.
Essential Fatty Acid Imbalance
Omega-3 fatty acids, particularly EPA and DHA, are important components of brain-cell membranes and normal neuronal function. An inadequate intake or imbalance of essential fatty acids may be relevant to mood, cognition and inflammatory regulation.
Where appropriate, I assess dietary intake and may recommend EPA/DHA-rich foods or supplementation as one part of a broader treatment plan.
Could Your Biochemistry Help Explain Why Treatment Hasn't Worked as Expected?
Biotyping can help investigate questions such as:
- Why did an antidepressant help one person but not another?
- Why can a supplement that helps someone else make you feel worse?
- Could methylation, copper, zinc, pyrroles or other biochemical factors be contributing to your symptoms?
A questionnaire can point towards possible patterns. Clinical assessment and laboratory testing are what allow us to investigate them properly.
If you’ve tried different medications, supplements or approaches and still feel that part of the picture is missing, a Walsh Protocol consultation can help us look at your individual biochemistry more closely.